Related Experiment Video

Updated: Jul 5, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
09:01

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

Update on medical and surgical management of intracerebral hemorrhage

Raymond Tak Fai Cheung1

  • 1Division of Neurology, University Department of Medicine, Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong. rtcheung@hkucc.hku.hk

Reviews on Recent Clinical Trials
|May 14, 2008
PubMed

Insights

Intracerebral hemorrhage (ICH) is a severe stroke type. Early treatment with recombinant activated factor VII shows promise in limiting hematoma growth and improving outcomes.

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Medicine

Background:

  • Intracerebral hemorrhage (ICH) constitutes a significant portion of stroke cases, carrying higher morbidity and mortality rates compared to ischemic strokes.
  • Primary ICH results from spontaneous arterial rupture due to hypertension or amyloid angiopathy, while secondary ICH stems from vascular abnormalities.
  • Current management is largely supportive, with limited improvement in patient outcomes despite advancements in understanding pathophysiology.

Purpose of the Study:

  • To review the current understanding and management strategies for intracerebral hemorrhage.
  • To evaluate the efficacy of novel treatments and prognostic scoring systems for ICH.
  • To explore the potential role of microbleeds in predicting future ICH risk.

Main Methods:

  • Review of recent literature on intracerebral hemorrhage pathophysiology, management, and outcomes.
  • Analysis of findings regarding surgical vs. conservative treatment approaches.
  • Evaluation of the impact of recombinant activated factor VII (rFVIIa) administration on hematoma expansion and patient outcomes.
  • Assessment of recently proposed ICH scoring systems for outcome prediction.
  • Consideration of the association between microbleeds and ICH risk.

Main Results:

  • Early surgical intervention for ICH has not demonstrated overall benefit compared to conservative management.
  • Treatment with recombinant activated factor VII within 4 hours of onset effectively limits hematoma growth at 24 hours, reducing mortality and improving 90-day functional outcomes.
  • New ICH scoring methods show potential utility in patient selection for clinical trials.
  • Microbleeds are frequently observed on MRI, but their association with future ICH risk requires further investigation.

Conclusions:

  • Recombinant activated factor VII represents a promising therapeutic option for acute intracerebral hemorrhage, improving key clinical outcomes.
  • ICH scoring systems may aid in stratifying patient risk and guiding clinical trial enrollment.
  • Further research is needed to elucidate the predictive value of microbleeds for future intracerebral hemorrhage events.

More Related Videos

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...